Monopar Therapeutics Inc

Market Cap

$431M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$59.48-$6.53 (-9.89%)

Jun 5, 2026

52W High $102.0552W Low $30.42

Company Details

Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. The company develops ALXN1840, a late-stage, investigational once-daily and oral med...

CEO

—

IPO Date

Dec 19, 2019

Website

www.monopartx.com

Key Metrics TTM

Revenue

- YoY

Net Income

-$15M

EPS (Diluted)

Free Cash Flow

-$10M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q1 2026

May 14, 2026

FY 2025

Mar 27, 2026

Q4 2025

Mar 27, 2026

Q3 2025

Nov 13, 2025

Q2 2025

Aug 12, 2025

Revenue & Profitability

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee